Skip to main content
. 2023 Nov 10;5:100191. doi: 10.1016/j.cccb.2023.100191

Table 3.

Performance on neuropsychological tests grouped according to specific cognitive domains.

GROUP 1
(n = 30)
GROUP 2
(n = 54)
GROUP 3
(n = 31)
p value
Episodic Memory, mean ± SD 78(±37) 61(±18) 69(±20) 0.014a
Cognitive Impairment (n°,%) 0(0.0%) 4(7.7%) 1(3.7%) 0.506
Language, mean ±SD 54(±7) 48(±13) 48(±13) 0.003b
Cognitive Impairment (n°,%) 1(3.4%) 3(5.8%) 3(11.1%) 0.531
Cognitive Processing Speed, mean ±SD 52(±22) 42(±23) 52(±21) 0.050
Cognitive Impairment (n°,%) 2(6.9%) 8(15.4%) 2(7.4%) 0.487
Attention, mean ±SD 58(±26) 69(±37) 73(±47) 0.276
Cognitive Impairment (n°,%) 0(0.0%) 2(3.8%) 0(0.0%) 0.496
Praxis, mean ±SD 35(±8) 33(±9) 36(±9) 0.173
Cognitive Impairment (n°,%) 3(10.3%) 6(11.5%) 2(7.4%) 0.919
Executive Functions, mean ±SD 151(±76) 146(±90) 149(±126) 0.817
Cognitive Impairment (n°,%) 1(3.4%) 5(9.6%) 3(11.1%) 0.551

NOTE: Group 1: Non-hypertensives; Group 2: Hypertensive with SBP < 140 and DBP < 90 mmHg; Group 3: Hypertensive with SBP ≥ 140 or DBP ≥ 90 mmHg; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; MMSE: Mini Mental State Examination; MoCA: Montreal Cognitive Assessment. The cognitive domain was considered compromised if it presented a z-score < −1.5 SD of the mean. using the normotensive group as a reference.

p values based on the Kruskal-Wallis test and Fischer's exact test.

a

significant post hoc comparisons (p < 0.05): group 1 vs. group 2.

b

significant post hoc comparisons (p < 0.05): group 1 vs. group 2 and 3.